ABSTRACT
Introduction
Cystic fibrosis (CF) is an autosomal recessive disease caused by the presence of mutations in a single gene on chromosome 7, which encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein [1] . CF originates different respiratory complications like pneumothorax, hemoptysis and allergic bronchopulmonary aspergillosis (ABPA) [2] . Pneumothorax is a frequent and life-threatening complication in patients with CF with an average annual incidence of 0.64% to 1% [3, 4] . Pneumothorax has been related to the presence of increased transpulmonary air pressure difference and lung hyperinflation due to chronic inflammation of the airways [5] . This respiratory complication worsens the prognosis of patients, since it increases their morbidity and mortality [6] .
The aim of the study was to analyze the risk factors associated with the presence of pneumothorax in patients with CF in the city of Madrid, and to describe the prognosis of patients following an episode of pneumothorax.
Patients and Methods

Patients
The patients were recruited from the CF specialized units from years 1989 to 2009. There were a total of 44 episodes of pneumothorax that experienced 17 of the 419 patients (4.1%) that are included in the CF patient database in the Community of Madrid. Ten patients were men (58.8%) and seven were women (41.2%), with a mean age of 23.82 ± 13.5 years-old (range 8 -72 years-old). The diagnosis of CF was established according to the clinical findings, the sweat chloride test and the genetic study [7] .
Also, a control group of 32 CF patients without pneumothorax was elected from the CF patient database. This group was integrated by 16 men (50%) and 16 women (50%) with a mean age of 20.43 ± 18.7 years-old (range 8 -28 years-old).
Methods
The variables that were retrieved for the analyses included: 1) demographic data: sex, age, date of birth and date of CF diagnosis; 2) data related to the pneumothorax: date of the first episode, number of recurrences, characteristics of each episode (side, size, symptomatology associated, manage); 3) microbiology: airways culture before the pneumothorax; 4) lung function tests (LFT) before and one year after the pneumothorax: forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC); 5) body mass index (BMI); 6) other respiratory complications (ABPA, hemoptysis); and 7) outcomes (mortality, lung transplant). In the control group, the same variables were retrieved with the exception of data related to pneumothorax; in these cases, we have chosen the first ant the last spirometry collected in the history of each patient. Confidentiality was kept for the data retrieved according to the Law of Data Protection.
Statistics
Statistical analyses were performed using SPSS version (SPSS v 17, Inc. Chicago, IL, USA). The demographic and clinical characteristics were expressed as mean ± SD or as percentages. Comparisons between quantitative variables were made using t-student or U-Mann Whitney test according to their normal distribution. Chi-square test was used to compare qualitative variables.
Results
Of the 419 patients registered in the CF patient database in the city of Madrid, 17 (4.06%) had experienced, at least, one episode of pneumothorax, collecting a total of 44 episodes, with an annual incidence of 0.5%. The mean age in the group with pneumothorax was 23.82 ± 13.51 years-old and in the control group was 20.46 ± 4.85 years-old. Both groups did not have significant differences comparing their mean age and proportion of sexes. In the group with pneumothorax, the mean age specified by sex was 23 ± 6.58 years-old (range 8 -33 years-old) for men and 26.57 ± 20.39 years-old (range 16 -72 years-old) for women (p > 0.05). The group with pneumothorax was divided according to the age of the first episode in two groups: <18 years and ≥18 years. There were four episodes of pneumothorax (24%) in the first group and 13 episodes (76%) in the second group. The difference of both groups was significant (p = 0.04). In the second group most patients were males (nine patients).
Nine patients had suffered only a single episode of pneumothorax (52.9%). The mean age of the first episode was 18.29 ± 9.6 years-old (range 5 -72 years-old). There were recurrences in eight patients (47.1%) ( Table  1) .
All patients had pulmonary and gastrointestinal involvement, with exception of one patient who was diagnosed of CF at the age of 72 years and who did not have gastrointestinal involvement.
In 20 episodes of pneumothorax (45.5%) it was localized in the right side and in 22 episodes (50%) it was left-sided. Two episodes (4.5%) were bilateral, one of which debuted with a cardiorespiratory arrest.
Regarding to the presentation, 43 (97.7%) episodes were symptomatic ( Table 2) . Chest pain (79.4%) and dyspnea (75%) were the most frequent symptoms for the clinical debut of pneumothorax. There were three episodes of tension pneumothorax (two recorded in the same patient), resulting one of them in a cardiopulmonary arrest.
With respect to the season in which pneumothorax occurred, eleven cases (78.57%) occurred in winter, seven (50%) in spring, seven (50%) in autumn and five In the same way, it was observed a non-significant difference between the number of episodes in spring or autumn comparing to them in winter, (p = 0.098). Also, the total number of pneumothorax episodes occurred in the most cold seasons or with greater climate variability (winter, spring and autumn), was higher than the number of episodes in summertime (p < 0.05).
Concerning microbiological cultures in the group with pneumothorax, Pseudomonas aeruginosa colonized the airways of 14 patients (82.4%). Other pathogens isolated were Staphylococcus aureus in three cases (17.6%), Haemophilus influenzae in two cases (11.8%), and both Klebsiella ozonae and Burkholderia cepacea in one case (5.8%) each one ( Table 3) . We found a significant difference comparing colonization by P. aeruginosa in the group with pneumothorax with respect to the control group (p = 0.002).
The nutritional status was established based upon the BMI. The group with pneumothorax had a mean BMI of 19.2 ± 2.42 kg/m 2 ; and in the control group it was 26.5 ± 1.98 kg/m 2 . Significant differences were found between both groups (p = 0.01).
With regard to the LFT, FVC and FEV 1 prior to the episode of pneumothorax were 62.5% ± 17.8% (range 45% -119%) and 43.4% ± 13.5% (range 20% -83%), respectively; and one year after the event, they were 45.2% ± 18.8% (range 22% -88%) and 32.5% ± 15.4% (range 18% -71%), respectively. The difference in the LFT before and after pneumothorax was significant in both parameters (p = 0.008) (Figure 1) . For the control group, we analyzed the first and the last LFT we had in the CF patient database. The initial FVC and FEV 1 were 84.8% ± 18.5% (range 47% -119%) and 82.53% ± 22.8% (range 25% -119%) respectively; and the last record for both parameters were 87.5% ± 21.51% (range 40% -146%) and 78.4 ± 25.6 (range 26% -136%) respectively. The difference between the first and the last LFT was not significant in both parameters. FVC and FEV 1 in the group with pneumothorax were lower than in the control group, both before and after pneumothorax (p < 0.05) (Figure 1) . ABPA was presented in six patients (53.4%) in the group with pneumothorax and in four patients (12.5%) in the control group. The difference was not significant.
Regarding treatment, eight (18.2%) episodes were resolved with conservative treatment, thirty-three (75%) with chest tube drainage-aspiration, nine (20.5%) with surgical pleurodesis, two (4.5%) with chemical pleurodesis, and one (2.3%) with suturing of bullaes ( Table 4) . There were recurrences in eight patients (47.1%), and one patient had nine recurrences.
At present, in the group with pneumothorax, three patients have needed lung transplantation (17.6%). Six patients (35.4%) have died, but only two (4.5%) in direct relation to the episode of pneumothorax. In the control group, two patients have died (6.3%). The difference of mortality between both group was statistically signify- 
Discussion
Survival in CF patients has increased in the recent years due to the early diagnosis and the creation of multidisciplinary treatment units [8] [9] [10] . This increased survival has been accompanied with the presence of a greater number of age-related complications such as pneumothorax. It is observed in our patients since most of them showed the first episode of pneumothorax beyond 18 years of age, indicating that this respiratory complication is more prevalent in those who have a longer survival, as is shown in the literature [3, 4, 11, 12] . Furthermore, in our study we have observed that patients who had their first episode after the 18 years were predominantly men. This is explained because, as already mentioned in the literature, women have a tendency to lower survival [13] . Similarly, almost 50% of patients with pneumothorax experienced recurrences. It might had been because treatments performed were less invasive and less aggressive than those used in pneumothorax caused by other diseases, given that many patients may specify in the future a lung transplant [14, 15] .
The most frequent symptoms of pneumothorax in our patients were dyspnea and chest pain, which coincides with that described in other series [3, 4, 16] . The number of episodes in each hemithorax was almost the same. Two patients had a bilateral pneumothorax, one of which debuted with a cardiorespiratory arrest, representing 2.3% of all cases. This form of presentation and the rate of occurrence are somewhat higher than that described by Graf-Deuel et al. [15] .
It has been discussed about the seasonal predominance in the appearance of pneumothorax, however information in patients with CF is scarce in this topic [18, 19] . We have found that this complication occurs predominantly in colder seasons or in seasons showing more climate variation as are fall, winter and spring time. One possible explanation would be that there are more atmospheric and barometric changes in these times of the year, which may increase the frequency of respiratory exacerbations and the frequency of treatments with physiotherapy or aerosols, which implies a change in intra-and extra-thoracic pressures.
Those patients with CF and pneumothorax had more frequent the presence of P. aeruginosa than other microorganisms in their airways. It is similar to results of other studies that concluded that colonization by P. aeruginosa doubles the likelihood of having a pneumothorax and that is associated with a greater and more rapid functional decline [3, 4, 15, 20] .
Regarding to the nutritional status, we have seen that the mean BMI of patients with pneumothorax was below the normal values. Some studies had postulated that the nutritional status in these patients is directly related to the respiratory prognosis [21, 22] . However, medical literature does not indicate any association between this index and the occurrence of pneumothorax in patients with CF. We believe that monitoring the nutritional status of CF patients is important to avoid further complications
The LFT were affected in the pneumothorax group. The low mean FEV 1 before the first episode of pneumothorax and its decrease suggest that these patients have a severe pulmonary involvement and that it worsens after a pneumothorax episode. As others authors have mentioned, a poor respiratory functional status favors the presence of certain pulmonary complications [12] . We have also found that this complication worsens the respiratory disorder of these patients. We therefore consider that pneumothorax clearly affects the morbidity of CF patients, as the literature postulate [3, 4, 11, 23] .
Thirteen patients with pneumothorax (76.4%) had gastrointestinal involvement. Six patients (35.2%) were receiving treatment or had been treated for ABPA, and it was not different from the control group. However, in the work of Flume et al. it was concluded that ABPA increases 1.5 the risk of having a pneumothorax [3] .
Regarding treatment, most authors agree that observation alone is only effective for small pneumothorax, where the risk of progression and of recurrence is low [3, [23] [24] [25] [26] . In our series, in agreement with other series, the most frequent method of therapy was chest tube drainage, although this method seems to be subject of recurrences [23, 24, 27, 28] . This conservative tendency to manage pneumothorax in CF patients is due to the difficulty to perform a future lung transplant. For this reason, the less intrusive methods are often used, even when bullectomy or surgical pleural abrasion have demonstrated that are the most effective methods and with less recurrences [4, 29] . At present, large pneumothorax (>20% of the hemithorax) are treated initially with chest tube drainage, and only those that are not resolved within seven to 15 days or that recourse, shall be treated with a more aggressive method such as the apical blebectomy with thoracoscopy, the ablation of blebs with laser and the apical thoracoscopic talc poudrage [25, 30, 31] . Chemical pleurodesis is reserved for patients with high surgical risk [23] .
Regarding mortality, six patients (35.3%) died in the group with pneumothorax, two directly related to pneumothorax and the remaining four within the five years of follow-up. In the control group, two patients (6.3%) died.
In relation to mortality, the differences were significant between both groups, probably due to the worsening of the respiratory function.
According to the Cystic Fibrosis Foundation Consensus Conference report, patients with CF should avoid maneuvers or situations which will create marked fluctuations in intrapleural pressure to prevent pneumothorax. These include intense isometric exercises. In the same way, no air travel or LFT should be undertaken for at least two weeks following resolution of a pneumothorax [32] [33] [34] .
In conclusion, the percentage of episodes of pneumothorax observed in our patients is similar to that described in the literature. Most of these episodes are symptomatic. Low nutritional status, respiratory involvement, P. aeruginosa positive-culture and the presence of cold seasons or with more variation in the climate are associated with the apparition of pneumothorax in CF patients. The occurrence of pneumothorax in CF is associated with worsening morbidity and mortality of patients.
Acknowledgements
Role of sponsors: No commercial sponsor had any involvement in the design and conduct of this study, namely collection, management, analysis, and interpretation of the data and preparation, decision to submit, review, or approval of the manuscript.
Financial/nonfinancial disclosures: Non conflict of interests indicated by the authors.
Other contributions: We want to thank to Mr. Ramiro Lopetegui due to his careful lecture and corrections of the manuscript.
